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Abstract. 
 
We have investigated the function of 
p55CDC, a mammalian protein related to Cdc20 and 
Hct1/Cdh1 in 
 
Saccharomyces cerevisiae
 
, and Fizzy and 
Fizzy-related in 
 
Drosophila
 
. Immunofluorescence stud-
ies and expression of a p55CDC-GFP chimera demon-
strate that p55CDC is concentrated at the kinetochores 
in M phase cells from late prophase to telophase. Some 
p55CDC is also associated with the spindle microtu-
bules and spindle poles, and some is diffuse in the cyto-
plasm. At anaphase, the concentration of p55CDC at 
the kinetochores gradually diminishes, and is gone by 
late telophase. In extracts prepared from M phase, but 
not from interphase HeLa cells, p55CDC coimmuno-
precipitates with three important elements of the M 
phase checkpoint machinery: Cdc27, Cdc16, and Mad2. 
p55CDC is required for binding Mad2 with the Cdc27 
and Cdc16. Thus, it is likely that p55CDC mediates the 
association of Mad2 with the cyclosome/anaphase-pro-
moting complex. Microinjection of anti-p55CDC anti-
body into mitotic mammalian cells induces arrest or de-
lay at metaphase, and impairs progression of late 
mitotic events. These studies suggest that mammalian 
p55CDC may be part of a regulatory and targeting 
complex for the anaphase-promoting complex.
 
P
 
rogression
 
 through mitosis requires regulated pro-
teolysis. Anaphase onset and the transition from M
to G1 phase are cued by protein destruction. A
number of putative proteolysis targets have been identi-
fied, including Pds1
 
1
 
 (precocious division of sister chroma-
tids), Mcd1/Scc1 (mitotic chromosome determinant/sister
chromatid cohesion), and Asc1 (anaphase spindle elonga-
tion) in 
 
S. cerevisiae 
 
(Cohen-Fix et al., 1996; Yamamoto et
al., 1996; Guacci et al., 1997; Michaelis et al., 1997; Juang
et al., 1997),
 
 
 
Cut2 in 
 
Schizosaccharomyces pombe
 
 (Fun-
abiki et al., 1996
 
a
 
; Funabiki et al., 1996
 
b
 
), and mitotic cy-
clins in a variety of species (Holloway et al., 1993; King et
al., 1995; Sudakin et al., 1995). Proteolysis of target proteins
occurs within the 26S proteosome. Substrates are first tar-
geted for destruction by polyubiquitination through the se-
quential actions of three enzymes: a ubiquitin-activating
enzyme (E1), a ubiquitin-conjugating enzyme (E2), and a
ubiquitin–ligase complex (E3). In M phase, an E3 complex
known as the anaphase-promoting complex (APC) or cy-
closome ubiquitinates, target proteins that contain a spe-
cific sequence motif termed the destruction box (Glotzer
et al., 1991). Recent evidence indicates that the timing of
substrate proteolysis in M phase occurs by regulating sub-
strate ubiquitination by the APC. However, since different
substrates (e.g., type A and B cyclins) appear to be proteo-
lyzed at different times in mitosis (Sigrist et al., 1995), sim-
ply turning the APC on or off cannot serve as the only regu-
latory mechanism.
A potential pathway for regulating APC activity is
through a mitotic checkpoint that monitors proper chro-
mosome attachment to the spindle. This checkpoint, called
the spindle checkpoint, guards the integrity of the cell divi-
sion by monitoring interactions of the mitotic spindle and
the kinetochores (reviewed in Rudner and Murray, 1996;
Gorbsky, 1997; Nicklas, 1997; Hardwick, 1998). In the
presence of one or more misaligned chromosomes, the
checkpoint temporarily inhibits the onset of anaphase un-
til all chromosomes achieve proper bipolar attachment to
the spindle. Control of this checkpoint appears to be based
on a mechanochemical system that senses the presence or
absence of physical tension mediated by microtubule at-
tachment at the kinetochores of chromosomes (Li and
Nicklas, 1995). Tension also regulates expression of a ki-
netochore phosphoepitope detected by the 3F3/2 mono-
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clonal antibody (Nicklas et al., 1995). Antibody microin-
jection experiments suggest that this phosphoepitope plays
a functional role in maintaining the checkpoint signal until
chromosome congression is complete (Campbell and
Gorbsky, 1995). Additional elements of the spindle check-
point were identified in budding yeast (reviewed in Rud-
ner and Murray, 1996). Yeast mutants of 
 
MAD1 
 
(mitosis
arrest–deficient), 
 
MAD2
 
, 
 
MAD3
 
, 
 
BUB1 
 
(budding unin-
hibited by benzimidazole), 
 
BUB2
 
, and 
 
BUB3
 
 genes ex-
hibit defective checkpoint function, progressing through
M phase when the spindle is disrupted with microtubule
poisons. Human and 
 
Xenopus 
 
homologs of Mad2
 
 
 
and a
murine homolog of Bub1 were identified, indicating that
checkpoint components are conserved from yeast to mam-
mals (Chen et al., 1996; Li and Benezra, 1996). Recently,
Li et al. (1997) presented evidence that human Mad2 pro-
tein binds to the APC in mitotic extracts of HeLa cells.
Moreover, depletion and add-back experiments in cycling
 
Xenopus
 
 extracts reported in the same study suggest that
Mad2 functions as an inhibitor of the APC.
Additional proteins appear to target substrates to the
APC at appropriate times. Evidence from yeast and 
 
Drosoph-
ila
 
 suggest that substrate selection may be directed by a
family of proteins related to Cdc20, first identified in 
 
S.
cerevisiae
 
 (Hartwell and Smith, 1985). All the known
members of the Cdc20 protein family: Cdc20 and Hct1/
Cdh1 of 
 
S. cerevisiae
 
 (Hartwell and Smith, 1985; Schwab et
al., 1997; Visintin et al., 1997),
 
 
 
Fizzy
 
 
 
and Fizzy-related of
 
Drosophila melanogaster
 
 (Dawson et al., 1993; Sigrist and
Lehner, 1997), and Slp1
 
 
 
of
 
 S. pombe
 
 (Matsumoto, 1997),
have previously been implicated in cell division regulation.
Originally, Cdc20 was found to be required for APC-
dependent degradation of Pds1 (Visintin et al., 1997),
while the related protein Hct1 was used for targeting yeast
mitotic cyclin Clb2 (Schwab et al., 1997). New evidence,
however, suggests that Cdc20 may be required in M phase
for degradation of both Pds1 and Clb2, while Hct1 may
function during G1 (Lim et al., 1998). Recently, a study in
 
S. pombe
 
 showed association of the Cdc20 homolog, Slp1,
with Mad2 protein (Kim et al., 1998). Similarly, two hybrid
and coimmunoprecipitation experiments indicate that
Cdc20 interacts with Mad2 as well as with Mad3 in 
 
S. cere-
visiae
 
 (Hwang et al., 1998). In 
 
Drosophila, 
 
mutation of the
 
fizzy
 
 locus causes metaphase arrest in 
 
Drosophila
 
 em-
bryos (Dawson et al., 1993) and prevents normal degrada-
tion of cyclins A and B during mitosis (Dawson et al.,
1995; Sigrist et al., 1995), while the protein produced by
the 
 
fizzy-related
 
 gene functions in the degradation of mi-
totic cyclins in G1 when cells have completed embryonic
divisions (Sigrist and Lehner, 1997).
In mammals, p55CDC, a putative member of the Cdc20
protein family, was identified by Weinstein et al. (1994).
The level of p55CDC protein fluctuates during the cell cy-
cle. Synthesis is initiated at G1/S; protein levels peak in M
phase, and the protein is abruptly degraded at the M/G1
transition (Weinstein, 1997). Degradation is blocked by
proteosome inhibitors, suggesting that p55CDC is targeted
by ubiquitin-mediated proteolysis. The p55CDC protein
also exhibits cell cycle changes in phosphorylation, immu-
nolocalization, and associations with other unknown pro-
teins, including some with kinase activity (Weinstein et al.,
1994; Weinstein, 1997).
In this study we investigate the function of the p55CDC
protein in M phase in mammalian cells. We demonstrate
that p55CDC is part of a complex containing both the
Mad2 protein, a component of the spindle checkpoint sig-
naling pathway, and the APC. Moreover, p55CDC ap-
pears to mediate the association between the Mad2 pro-
tein and the APC. By antibody microinjection experiments
we present evidence that p55CDC is required for normal
metaphase-to-anaphase transition and for late mitotic
events. Our evidence is consistent with a role for p55CDC
as a component of a cell cycle–regulated inhibitory com-
plex of APC or in targeting the APC to mitotic substrates
whose timely degradation is required for the metaphase-
to-anaphase transition, for anaphase chromatid move-
ment, and for exit from mitosis.
 
Materials and Methods
 
Cell Culture
 
Adherent and suspension cell cultures were maintained as previously de-
scribed (Campbell and Gorbsky, 1995; Renzi et al., 1997). For microinjec-
tion experiments, cells were cultured on gridded coverslips sealed with sil-
icone grease over holes cut in the bottoms of 60-mm plastic Petri dishes.
The chambers were sterilized by inverting them on a 365-nm UV light box
for 20 min before use.
 
Immunofluorescence
 
Antibodies were prepared to the COOH-terminal region of p55CDC as
previously described (Weinstein et al., 1994). The antibody to 
 
Xenopus
 
Mad2 protein (Chen et al., 1996) was provided by Drs. Rey-Huei Chen
and Andrew Murray, and the antibody to human Cdc27 (Tugendreich et al.,
1995) was provided by Drs. Stuart Tugendreich and Phil Hieter. Mono-
clonal 3F3/2 antibody, originally produced by Cyert et al. (1988), was used
as previously reported (Gorbsky and Ricketts, 1993). Immunofluores-
cence was essentially performed as described earlier (Gorbsky and Rick-
etts, 1993; Campbell and Gorbsky, 1995). In brief, for p55CDC and 3F3/2
immunofluorescence, cells on coverslips were simultaneously fixed and
extracted for 15 min in 0.2% Triton X-100 in PHEM (60 mM Pipes, 25 mM
Hepes at pH 6.9, 10 mM EDTA, and 4 mM MgCl
 
2
 
) containing 2.0% form-
aldehyde and 100 nM of phosphatase inhibitor microcystin LR (Calbiochem
Novabiochem, San Diego, CA). Cells on the coverslips were incubated in
primary antibodies for 45 min at a dilution of 1:450 of anti-p55CDC (1.0
 
m
 
g/ml) or 1:2,500 of 3F3/2 ascites. In some experiments, human sclero-
derma autoimmune serum (a gift of Dr. J.B. Rattner, University of Cal-
gary) was used at a dilution of 1:500 to label kinetochores. Cy3-conjugated
goat anti-mouse IgG (Jackson ImmunoResearch Laboratories, West Grove,
PA) was used at 1:650 to visualize 3F3/2; fluorescein-conjugated goat anti–
rabbit (Jackson ImmunoResearch Laboratories) at 1:450 to visualize anti-
p55CDC, and fluorescein-conjugated goat anti–human (Jackson Immu-
noResearch Laboratories) at 1:400 to visualize CREST antibodies. DNA
was counterstained with DAPI (Sigma Chemical Co., St. Louis, MO) at
0.3 
 
m
 
g/ml in distilled water, or with 0.1 nM Yo-Pro (Molecular Probes, Eu-
gene, OR).
Fluorescently labeled cells were analyzed with a Diaphot™ microscope
(Nikon Inc., Melville, NY) equipped with a microchannel plate image in-
tensifier and video rate CCD camera (DAGE-MTI, Michigan City, IN),
and was digitized with Image 1 software (Universal Imaging Corp., West
Chester, PA). Some images were obtained with a digitally cooled CCD
camera (Photometrics Ltd., Tucson, AZ) using Metamorph software
(Universal Imaging Corp.). Images were further processed using Meta-
morph, Corel Photopaint, and Corel Draw software and printed with an
8600 printer (Eastman Kodak Co., Rochester, NY).
 
Transfection with p55CDC-GFP
 
The full-length coding sequence for p55CDC was inserted between the
HindIII and BamHI sites of pEGFP-N3 obtained from Clontech (Palo
Alto, CA). LLC-PK1 cells were subcultured on 22-mm coverslips in 60-mm
plastic Petri dishes, and were transfected by calcium phosphate coprecipi- 
Kallio et al. 
 
p55CDC Regulates Cell Division Progression
 
1395
 
tation. Control cultures were transfected with the plasmid pEGFP-N1 (Clon-
tech) that coded for GFP without p55CDC. 8–24 h after transfection, the
cells were fixed with 4% formaldehyde, counterstained with DAPI, and
mounted with Prolong antifade kit (Molecular Probes).
 
Immunoprecipitation
 
HeLa cells were obtained from unsynchronized populations, or from cells
arrested in M phase with colcemid as described (Renzi et al., 1997). Cells
were washed with PBS and used immediately, or were frozen in liquid ni-
trogen and stored at 
 
2
 
70
 
8
 
C. The cells were lysed in APC buffer (20 mM
Tris-HCl, pH 7.7, 100 mM KCl, 50 mM sucrose, 0.1 mM CaCl
 
2
 
, 1 mM
MgCl
 
2
 
, 0.5% Triton X-100) with 400 nM microcystin LR (Calbiochem
Novabiochem) and 5 
 
m
 
g/ml of protease inhibitors (Leupeptin, Pefablock
and Pepstatin A) for 5 min on ice with intermittent vortexing. The extracts
were centrifuged at 15,000 
 
g
 
 for 10 min at 4
 
8
 
C, and the supernatants were
used for immunoprecipitation. Polyclonal anti-p55CDC antibody pre-
pared against the full-length bacterially expressed p55CDC (Weinstein et al.,
1994), polyclonal anti-Cdc27 prepared against a COOH-terminal frag-
ment of Cdc27 protein (Tugendreich et al., 1995), and a monoclonal anti-
Cdc27 antibody obtained commercially (Transduction Laboratories, Lex-
ington, KY) were used for immunoprecipitation experiments. Antibodies
were precoupled to either Protein A or Protein G Sepharose (Pierce
Chemical Co., Rockford, IL) by incubating 10 
 
m
 
g of antibody with 200 
 
m
 
l
of protein bead slurry in the APC buffer for 
 
z
 
1 h at 4
 
8
 
C. 1,000 
 
m
 
l of the
extract was mixed with 200 
 
m
 
l of the antibody/protein bead complex in the
APC buffer, and was incubated at 4
 
8
 
C for 3 h. After incubation, the washed
immunoprecipitate and the supernatant were collected for Western blot-
ting analysis and immunoprecipitations. In some cases, supernatants from
one immunoprecipitation were used a second time for another immuno-
precipitation with a different antibody. After the second immunoprecipi-
tations, the washed immunoprecipitate and the remaining supernatants
were collected for immunoblotting analysis.
 
Immunoblotting
 
Whole cell lysates, cell extracts, immunoprecipitations, and supernatants
remaining from immunoprecipitation experiments were prepared in sam-
ple loading buffer with 
 
b
 
-mercaptoethanol. Electrophoresis was carried
out on 5–20% SDS-polyacrylamide gradient gels. The proteins were trans-
ferred to an Immobilon-P membrane (Millipore Corp., Bedford, MA).
The membranes were blocked with 5% BSA in TBST (10 mM Tris, 150
mM NaCl, 0.05% Tween 20) for 30 min, washed, and incubated either
with rabbit anti-p55CDC (1 
 
m
 
g/ml in TBST), mouse monoclonal anti-
CDC27 (125 ng/ml in TBST), rabbit anti-Cdc27 (1:6,000 in TBST), rabbit
anti-Cdc16 (1:6,000 in TBST), or with rabbit anti-Mad2 (100 ng/ml in
TBST) for 1.5 h. The washed membranes were incubated with HRP-con-
jugated AffiniPure donkey anti–rabbit IgG, AffiniPure goat anti–rabbit IgG,
or goat anti–mouse IgG (Jackson ImmunoResearch Laboratories) 1:2,5000
in TBST for 1 h. The proteins were visualized using chemiluminescent Re-
naissance Kit (Dupont-NEN, Boston, MA). Some immunoblots were re-
probed using anti-Cdc16 antibodies after stripping with 0.2 N NaOH.
 
Live Cell Experiments and Microinjection
 
Anti-p55CDC antibody concentration was determined with the BCA as-
say (Pierce Chemical Co.). Antibody was injected in either Tris-glycine
(0.05 M Tris, 0.1 M glycine) or KCl-PO
 
4
 
 (0.1 M KCl, 1.7 mM NaCl, 8.1 mM
Na
 
2
 
HPO
 
4
 
, 1.5 mM KH
 
2
 
PO
 
4
 
) buffer. Neither buffer showed any effect on
normal mitotic progression when injected without antibody. For control
microinjections, rabbit IgG (Sigma Chemical Co.) diluted to 8.0 mg/ml
with either Tris-glycine or KCl-PO
 
4
 
 was used. Cells were cultured on
marked glass coverslips, and microinjections were performed essentially
as previously described (Campbell and Gorbsky, 1995). In brief, the me-
dium in the culture chamber containing the coverslip was overlaid with
mineral oil to prevent evaporation. The dish was placed on the pre-
warmed stage of a Diaphot™ microscope (Nikon Inc., Rockville, MD)
and maintained at 36–37
 
8
 
C with a warm air curtain incubator (Sage, Bos-
ton, MA).
For live cell observations and microinjection, a dry 40
 
3
 
 objective (Ni-
kon, Inc.) was used with a long working distance condenser and video
rate, charge-coupled device camera. Microinjections were performed with
a micromanipulator (Narishige USA, Inc., Greenvale, NY) using freshly
pulled glass microneedles. Cells were microinjected at different phases of
division, ranging from late prophase to early anaphase. After microinjec-
tion, cells were monitored using planapochromat 60
 
3
 
 (N.A. 1.4) or neo-
fluar 100
 
3
 
 (N.A. 1.3) objectives (Nikon, Inc.) with a short working dis-
tance condenser. Images were recorded in one of two ways. Images
captured with a video rate CCD camera and 16-frame averages were digi-
tized with Image 1 software after subtracting background. Images were
captured alternatively with a digital cooled CCD camera using Meta-
morph software.
 
Results
 
Characterization of Antibodies
 
Western blotting analysis of cycling and mitotic HeLa cells
and cycling PtK1 cells with antibody against the COOH-
terminal region of p55CDC reveals a protein band at 55 kD
(Fig. 1). Two additional faint protein bands were present
in PtK1 cell at 
 
z
 
40 and 70 kD.
 
p55CDC is Present Diffusely and Concentrates at the 
Kinetochores of M Phase Chromosomes
 
To examine cell cycle–dependent changes in the localiza-
tion of p55CDC, we performed immunofluorescence stud-
ies in cultured HeLa and PtK1 cells. In interphase of HeLa
and Ptk1 cells, faint diffuse labeling throughout the cell
was observed (Fig. 2). In early prophase, diffuse labeling
throughout the cell was evident with a concentration of la-
bel within the nucleus. Beginning with late prophase, dou-
ble-dot labeling was observed at the primary constriction
of all chromosomes. Colocalization with human autoim-
mune antibodies confirmed that double-dot labeling was
at the kinetochores. p55CDC was present at the kineto-
chores of chromosomes from late prophase to telophase in
both HeLa (Fig. 2 
 
A
 
) and PtK1 cells (Fig. 2 
 
B
 
). The
p55CDC label at the kinetochores was most intense during
prometaphase and metaphase. During anaphase, the kine-
tochore labeling gradually diminished, and ultimately dis-
appeared by late telophase. In cells extracted with 1%
CHAPS detergent before fixation, kinetochore labeling in
mitotic cells was diminished.
Similarly, in LLC-PK1 cells expressing p55CDC-GFP
chimeric protein, the kinetochores were p55CDC-positive
from late prophase to late anaphase (Fig. 3 
 
A
 
). In addition
to the bright labeling at the kinetochores, p55CDC-GFP
was present diffusely, and also concentrated at the spindle
poles and along the kinetochore fiber microtubules through-
out M phase (Fig. 3 
 
A
 
). Interphase centrosomes also con-
tained concentrations of p55CDC-GFP. In prometaphase
cells, the intensity of p55CDC-GFP at the kinetochores
varied among chromosomes depending on their degree of
Figure 1. Expression of p55CDC
in proliferating mammalian cells.
The antibody recognizes a 55-kD
band (arrow) in whole HeLa cell
extracts from both cycling cul-
tures (cycl) and after mitotic ar-
rest (mitot). In whole cycling
PtK1 cell extracts, the anti-
p55CDC antibody recognizes
primarily a 55-kD band, although
slight reactivity is seen with two
other bands at z40 and z70 kD. 
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congression to the metaphase plate. Chromosomes near
one of the spindle poles showed brighter kinetochore la-
beling than did chromosomes at the spindle equator (Fig. 3
 
A
 
). In many cases, one or a few chromosomes remained
misaligned when all the others had moved to the metaphase
plate. These lagging chromosomes always exhibited more
intense p55CDC-GFP signals (Fig. 3 
 
A
 
). Similar differ-
ences in apparent concentration of p55CDC at kineto-
chores were seen with immunofluorescence experiments
(Fig. 2), but were more evident with p55CDC-GFP. No
apparent difference was observed in the intensity of the
p55CDC-GFP signal between the leading kinetochore and
the trailing kinetochore of individual prometaphase chro-
mosomes (Fig 3 
 
A
 
). Control cells expressing the GFP
Figure 2. Immunofluorescent localization of p55CDC in HeLa and PtK1 cells. (A) HeLa cells. The left column shows DNA (DAPI
staining), the middle column shows kinetochores (human autoimmune antibody), and the right column shows p55CDC labeling. At
prophase, diffuse labeling is seen throughout the cells with a concentration at the kinetochores. The kinetochore localization is apparent
from late prophase to telophase. During anaphase, kinetochore labeling diminishes and is lost by the end of telophase. The diffuse cyto-
plasmic labeling persists until the M-to-G1 transition. (B) PtK1 cells. The left column shows DNA (Yo-Pro staining) and kinetochores
(human autoimmune antibody). The middle column demonstrates p55CDC staining at different stages of mitosis where intensity and
contrast settings have been optimized for each individual panel. This technique permits visualization of the staining at anaphase and telo-
phase. The right column shows p55CDC labeling in which intensity and contrast settings were kept constant for all stages, allowing com-
parison of the relative intensity of labeling at different stages of mitosis. The top set of panels, taken at low magnification, shows a field
of cells with some in G2 (arrowheads) and one in prophase (arrow). p55CDC relocalizes from the diffuse cytoplasmic/nuclear pool to
the kinetochores of chromosomes just before NEB. Kinetochores show different intensities of labeling during prometaphase. At
prometaphase, the kinetochores near the spindle poles often possess brighter signals (arrows) compared with ones that are closer to the
spindle equator (arrowhead). The box (3 mm on either side of the spindle equator) used to define metaphase is shown. During anaphase,
the anti-p55CDC signal gradually diminishes at the kinetochores, and ultimately disappears by late telophase. Bars, 5 mm. 
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alone showed only a diffuse fluorescence, and did not ex-
hibit concentrations of fluorescence on mitotic organelles
(Fig. 3 
 
B
 
).
 
p55CDC Binds Mad2 and the Anaphase-promoting 
Complex in Mitotic Cell Extracts
 
Anti-p55CDC immunoprecipitates made from mitotic
HeLa cell extracts (at least 70% mitotic cells) contained
Mad2, a checkpoint pathway protein, and Cdc27, a compo-
nent of the APC (Fig. 4 
 
A
 
). In contrast, extracts prepared
from unsynchronized HeLa cell cultures (less than 5% mi-
totic cells) showed little association between p55CDC and
Mad2 or Cdc27.
In mitotic HeLa cell extracts immunodepleted of all de-
tectable p55CDC, substantial amounts of Mad2 protein
and Cdc27/Cdc16 (APC component proteins) remained.
To test if Mad2 was bound to the APC independently of
p55CDC, we performed sequential immunoprecipitation
experiments. We first immunoprecipitated the p55CDC
protein from the mitotic extracts. As expected, a portion
of Mad2 and Cdc27/Cdc16 coimmunoprecipitated, but
much remained in the extract. We then used anti-Cdc27
antibody to immunoprecipitate the residual APC in the
extract. We found only trace amounts of Mad2 bound to
this residual APC (Fig. 4 
 
B
 
). Thus, Mad2, when not com-
plexed with p55CDC, does not bind the APC.
To determine if p55CDC and Mad2 are complexed with
each other in the absence of the APC, we first immunode-
pleted the APC from the mitotic extracts with anti-Cdc27
antibody (Fig. 4 
 
C
 
). A large amount of Mad2 remained in
the supernatant. From this supernatant we again immuno-
precipitated, this time with anti-p55CDC, and then immu-
noblotted with anti-Mad2 antibody. p55CDC was com-
pletely removed by the immunoprecipitation, and a substantial
amount of Mad2 protein was coimmunoprecipitated. How-
ever, some Mad2 also remained in the second supernatant
(Fig. 4 
 
C
 
). Therefore, in mitotic HeLa cell extracts, Mad2
complexes with p55CDC in the absence of the APC and
some Mad2 is not associated with either p55CDC or APC.
In summary, the immunoprecipitation experiments indi-
cate that Mad2 is present in two pools: one associated with
p55CDC and one not. Only in the presence of p55CDC
does Mad2 also associate with the APC. Since p55CDC as-
sociates with Mad2 in the absence of the APC, the sim-
plest interpretation is that p55CDC and Mad2 must be
present in a complex in order to bind to the APC. How-
 
Figure 3.
 
(
 
A
 
) Fixed LLC-PK1 cells expressing chimeric GFP-
p55CDC. In interphase cells, a pair of dots at the centrosome (
 
ar-
row
 
) is brightly labeled throughout the cell cycle. In mitotic cells,
the p55CDC-GFP concentrates at the kinetochores from late
prophase to late anaphase. A pool of the protein also remains dif-
fusely distributed. In addition, the spindle poles (
 
arrows
 
) and the
kinetochore microtubules show concentrations of the p55CDC-
GFP. During prometaphase, the intensity of the kinetochore
p55CDC-GFP signal is more intense at the kinetochores of un-
aligned chromosomes located near the spindle poles (
 
black arrow-
heads
 
) compared with the kinetochores of chromosomes aligned at
metaphase plate (
 
white arrowheads
 
). No apparent difference is
seen in intensity of the p55CDC-GFP signal between the leading
and the trailing kinetochore of individual unaligned chromosome
(
 
small arrows in prometaphase row
 
). In anaphase cells, the spindle
poles (
 
big arrows
 
) remain p55CDC-GFP-positive while kineto-
chore labeling diminishes. (
 
B
 
) An interphase and a mitotic LLC-
PK1 cell expressing the GFP alone show no specific fluorescent ki-
netochore, spindle microtubule, or spindle pole signals. Bars, 5 
 
m
 
m. 
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ever, it is likely that other proteins are involved in the
binding of Mad2, p55CDC, and the APC.
 
Microinjection of Mitotic HeLa Cells with
Anti-p55CDC Induces a Delay at Metaphase
To examine the function of p55CDC in living mammalian
cells, we microinjected anti-p55CDC antibody or control
rabbit IgG into prometaphase HeLa cells. In control cells
(n 5 10) the average duration of metaphase was 15.2 6 4.6
min (range 9–22 min), and the average length of anaphase
was 3.2 6 0.9 min (range 2–6 min; Table I).
Microinjection of prometaphase HeLa cells (n 5 19)
with anti-p55CDC (micropipette concentration 2.0 mg/ml)
caused a transient metaphase arrest (Fig. 5 A). The cells
delayed onset of anaphase significantly (35.0 6 30.7 min;
range: 7–109 min) when compared with control IgG-injected
cells (P , 0.01, Table I). In addition, the duration of
anaphase was slightly longer in the anti-p55CDC injected
HeLa cells (5.7 6 3.0 min; range: 3–13 min), although the
difference from controls was not statistically significant
(P , 0.1).
Microinjection of PtK1 Cells with Anti-p55CDC 
Causes Mitotic Defects
To study the effects of anti-p55CDC antibody injection in
more detail, we injected prophase-to-early metaphase
PtK1 cells either with anti-p55CDC antibody (n 5 31, mi-
cropipette concentration 1.0–2.5 mg/ml) or with nonspe-
cific rabbit IgG antibodies (n 5 32, 8.0 mg/ml). In control
PtK1 cells, the average duration of metaphase was 10.8 6
4.7 min (range 4–23 min), and the average length of
anaphase was 9.3 6 4.0 min (range 3–16 min; Table I).
Cells injected with anti-p55CDC at late metaphase (8
min after the last chromosome had arrived to the meta-
phase plate; n 5 2) or at early anaphase (n 5 3) showed no
apparent effects. Duration of anaphase in these cells was
6.6 6 0.9 min. Cells injected between late prophase and
early metaphase exhibited several mitotic defects when
compared with control injected cells (Fig. 6). The fre-
quency of specific defects did not correlate with the phase
of mitosis in which the antibody was introduced. In
prophase cells, identical effects were observed whether the
cells were injected in the nucleus or the cytoplasm. Mitotic
PtK1 cells microinjected with anti-p55CDC antibody be-
fore late metaphase showed three main responses (Table
I): (a) metaphase arrest/delay in anaphase onset; (b) slow
anaphase; and (c) failure to exit mitosis. In all, 29 of 31
cells (94%) injected before late metaphase showed at least
one type of deficiency. Many cells showed a combination
of responses, of which the most frequent was a delay in the
onset of anaphase followed by slow poleward chromatid
movement. The other two injected cells (6%) progressed
through mitosis normally (Fig. 6).
As with HeLa cells, the most frequent outcome of anti-
p55CDC microinjection into PtK1 cells was a delay in the
by immunoprecipitation with anti-Cdc27 protein. The APC-
depleted extract was then used for a second immunoprecipitation
with anti-p55CDC. In the absence of APC components, a sub-
stantial portion of the Mad2 protein is complexed with p55CDC.
Figure 4. p55CDC binds to Mad2 protein and to the APC. (A)
Cdc27 and Mad2 proteins are detected in anti-p55CDC immuno-
precipitates from mitotic, but not interphase HeLa cell extracts
(Cdc27 protein is indicated in two locations since it undergoes a
phosphorylation shift in M phase). Mad2 and p55CDC proteins
are detected in anti-Cdc27 immunoprecipitates from mitotic, but
not interphase HeLa cell extracts. (B) A sequential immunopre-
cipitation experiment showing that p55CDC is necessary for
Mad2 binding to the APC. A mitotic extract of HeLa cells was
first immunodepleted of p55CDC protein (left). Some of the
APC remains in the supernatant. The p55CDC-depleted extract
was then used in a second immunoprecipitation with anti-Cdc27
antibody. In the absence of p55CDC, almost none of the remain-
ing Mad2 coprecipitates with the Cdc27 protein. (C) Sequential
immunoprecipitation experiment demonstrating that p55CDC
and Mad2 form complexes independent of the APC. The mitotic
HeLa cell extract was first immunodepleted of APC componentsKallio et al. p55CDC Regulates Cell Division Progression 1399
onset of anaphase which varied in duration among individ-
ual cells. Ten out of 31 cells (32%) injected with anti-
p55CDC antibody before late metaphase failed to initiate
anaphase within 90 minutes after the last chromosome
reached the metaphase plate. As a rule, after 90 min in
metaphase, observation of a cell was suspended, and it was
categorized as permanently arrested at metaphase (Table
I, Fig. 5 B, Fig. 6). Some of these cells were cultured over-
night to determine if they would remain arrested. The cells
were still arrested at M phase with condensed chromo-
somes the following morning.
In addition to the permanently arrested cells, a number
of PtK1 cells microinjected with anti-p55CDC antibody
exhibited a transient metaphase arrest (Table I, Fig. 7 A)
Figure 5. Microinjection with antibodies
against p55CDC hampers the metaphase-
to-anaphase transition. (A) Anti-p55CDC
microinjection induces a transient
metaphase arrest in HeLa cells. The anti-
body (2.0 mg/ml in the micropipette) was in-
jected at prometaphase 18 min before the
metaphase plate formed (time 0 5 meta-
phase). (a) The first image was taken 5 min
after injection. (b–f) During the metaphase
arrest, the chromosomes underwent occa-
sional stretching, but were rapidly pulled
back to form a tight metaphase plate. (f)
The onset of anaphase occurred 103 min af-
ter the tight metaphase plate formed for
the first time. (f–g) Separation and move-
ment of the sister chromatids required 13
min, which is slightly longer than the aver-
age of control cells. (g–h) Cytokinesis and
exit from mitosis appeared normal. (B)
Anti-p55CDC microinjection induces meta-
phase arrest in PtK1 cells. The cell was in-
jected with anti-p55CDC (2.0 mg/ml) at late
prophase a few minutes before breakdown
of the nuclear envelope. (a) The first image
was taken 5 min later, when the cell was at
early prometaphase. (b) The last chromo-
some (arrowhead) became bioriented 17 min
before the metaphase plate was formed.
Progression through prometaphase appeared
normal. (c) The last chromosome aligned at
the spindle equator, and a metaphase plate
was formed. The box (3 mm on either side of
the spindle equator) used to define the start
of metaphase is shown. (c–f) The cell did
not initiate anaphase during the time it was
monitored (total time 5 168 min after the be-
ginning of metaphase). Bars, 5 mm.
Table I. Cell Cycle Progression in HeLa and PtK1 Cells Injected with Control Rabbit IgG or Anti-p55CD
Injection/cell phase injected n
No. of cells arrested
at metaphase
Duration of metaphase
in min (mean 6 SD)
Duration of anaphase
in min (mean 6 SD) Specific notes
HeLa
control rabbit IgG‡ 10 0 15.2 6 4.6 3.2 6 0.9
early/late prometaphase
anti-p55CDC‡ 19 0 35.0 6 30.7i 5.7 6 3.0
early/late prometaphase
PtK1
control rabbit IgG 32 0 10.8 6 4.7 9.3 6 4.0
late prophase/early metaphase 3 arrested at early anaphase
anti-p55CDC§ 31 10 38.0 6 20.7i 23.3 6 13.1i 4 arrested at late anaphase
late prophase/early metaphase 5 without cytokinesis
*8.0 mg/ml in KCl-buffer. ‡2.0 mg/ml in KCl-buffer. §1.0-2.5 mg/ml in KCl- or Tris-buffer. iP , 0.01.The Journal of Cell Biology, Volume 141, 1998 1400
with an average duration of 38.0 6 20.7 min (range, 8–75
min). The duration of metaphase exhibited by these tran-
siently arrested cells is significantly greater (P , 0.01) than
that of control cells.
Microinjection of Mitotic PtK1 Cells with
Anti-p55CDC Impairs Sister Chromatid Separation at 
Anaphase, Hampers Cytokinesis, and Exit from
M phase
Most of the PtK1 cells that eventually proceeded to
anaphase after anti-p55CDC microinjection showed atypi-
cal features, including failure to separate sister chromatids
or impaired sister chromatid movement after anaphase
onset. The most common type of deficiency was a very
slow poleward movement of the chromatids during ana-
phase, even after the chromatids had separated (Fig. 7 A).
The average duration of anaphase in those anti-p55CDC
microinjected PtK1 cells that initiated anaphase either af-
ter a normal or prolonged metaphase was 23.3 6 13.1 min
(range: 6–48 min), a time significantly greater (P , 0.01)
than that of cells injected with control IgG (Table I).
Three of the anti-p55CDC microinjected cells arrested
in early anaphase, failing to separate their chromatids
completely (Fig. 7 B). Anaphase onset was evident in
these cells. The kinetochore regions of the chromosomes
stretched and pulled apart, but the chromosome arms did
not fully separate. These cells remained arrested at this
early anaphase configuration for hours.
A third type of deficiency observed in the cells microin-
jected with anti-p55CDC antibody was the failure to de-
condense the chromosomes and exit mitosis. 4 out of 21
anti-p55CDC microinjected cells (19%) that eventually
progressed into anaphase did not exit M phase. Instead,
the cells were arrested at late anaphase-like configuration
with condensed chromatids at the poles. 5 of 21 cells
(24%) failed to initiate cytokinesis, but did decondense
their chromosomes, reformed nuclear envelopes, and pro-
gressed into the next cell cycle as binucleate cells (Fig. 7 A).
To investigate whether the anti-p55CDC injection af-
fects cell cycle progression at prometaphase, we moni-
tored chromosome movements from nuclear envelope
breakdown (NEB) to metaphase in cells that were injected
at late prophase either with anti-p55CDC antibody or
nonspecific rabbit IgG. The duration of prometaphase in
anti-p55CDC–injected cells was not significantly different
from uninjected or control-injected cells from similar cul-
tures (Table II). However, again onset of anaphase was
significantly delayed by anti-p55CDC antibody injection,
and cells were observed to arrest at metaphase (Table II).
At various times after microinjection, cells were fixed
and labeled with a fluorescent anti-rabbit secondary anti-
body to track the fate of the microinjected anti-p55CDC
antibody. The anti-p55CDC antibody bound to kineto-
chores within a few seconds after injection (data not
shown). Interestingly, in microinjected cells that did com-
plete anaphase and exit M phase, the antibody remained
bound at the kinetochore region of the late telophase/
early G1 nuclei as demonstrated by colabeling with Crest
autoimmune sera (Fig. 8). This result is in contrast to the
results obtained with conventional immunofluorescence,
where labeling of kinetochores fades as cells reach telo-
phase (Fig. 2).
Microinjection with Anti-p55CDC Does
Not Perturb Expression of the 3F3/2 Phosphoepitope
at Kinetochores
We have postulated that the kinetochore phosphoprotein
recognized by the 3F3/2 anti-phosphoepitope is a compo-
nent of the spindle checkpoint. To investigate the possibil-
ity that the metaphase arrest induced by anti-p55CDC mi-
croinjections could result from activation of the spindle
checkpoint upstream of the 3F3/2 phosphoepitope, cells
microinjected with anti-p55CDC were probed with 3F3/2
antibody. 3F3/2 phosphoepitope expression was not al-
tered in cells microinjected with anti-p55CDC (Fig. 9 A).
The 3F3/2 signal at the kinetochores was lost by meta-
phase as the chromosomes aligned at the spindle equator.
If cells were microinjected with anti-p55CDC, allowed to
proceed into metaphase, and subsequently treated with
the microtubule poison nocodazole, the 3F3/2 phospho-
epitope reappeared at all kinetochores (Fig. 9 B). As we
had shown previously, the intensity of 3F3/2 phospho-
epitope expression varied among the kinetochores of
prometaphase cells, diminishing as the chromosomes align
at the metaphase plate. We found that labeling with anti-
p55CDC paralleled the changes seen with the 3F3/2 anti-
body. As chromosomes became aligned, their labeling
with the anti-3F3/2 antibody diminished (Fig. 9 A). How-
ever, unlike the 3F3/2 antibody labeling, labeling with
anti-p55CDC antibody persisted in metaphase and, albeit
more weakly, in anaphase (Fig. 9 A; Fig. 2).
Figure 6. Cell cycle progression in PtK1 cells injected with non-
specific rabbit IgG (8.0 mg/ml) or anti-p55CDC (1.0–2.5 mg/ml).
The numbers above the bars denote the proportion of cells in
each category. Control IgG or anti-p55CDC injected cells were
considered to exhibit a delay at metaphase if the duration of
metaphase was more than double the mean duration of meta-
phase in the control cells. Cells were considered to exhibit an
aberrant anaphase if they arrested during anaphase or if the du-
ration of anaphase was more than double the mean duration of
anaphase in control cells.Kallio et al. p55CDC Regulates Cell Division Progression 1401
Discussion
We have investigated the M phase role of p55CDC, a
mammalian protein related to Cdc20 and Hct1/Cdh1 in S.
cerevisiae, and to fizzy and fizzy-related gene products in
Drosophila. By immunofluorescence and by expression of
a p55CDC-GFP fusion protein, we determined that p55CDC
is present diffusely and also concentrated at kinetochores
and spindle poles in M phase cells. In extracts of M phase
cells, we found that p55CDC associates with Mad2, an ele-
ment of the spindle checkpoint pathway, and with the
APC, the 20S ubiquitin ligase complex. Moreover, we dis-
covered that p55CDC was necessary for the interaction
between Mad2 and the APC. To test the function of
p55CDC in M phase, we injected anti-p55CDC antibody
into M phase cells. Anti-p55CDC caused several alter-
ations in mitosis, including metaphase arrest, delayed
anaphase onset, aberrant chromatid movement in anaphase,
and inhibition of exit from M-phase.
p55CDC Associates with Kinetochores of 
Chromosomes in M Phase
Kinetochores play multiple roles in M phase. Classically
they were found to be essential for equal segregation of
chromosomes in meiosis and mitosis. A number of micro-
tubule motor proteins reside at the kinetochore (Rudner
and Murray, 1996; Yen and Schaar, 1996), and in vitro ex-
periments demonstrate that chromosomes, presumably by
action of their kinetochores, are capable of translocation
on microtubules (Hyman and Mitchison, 1991; McIntosh,
1991). Recently it was recognized that kinetochores play
an additional critical role as signaling organelles in cell cy-
cle regulation. Most cells delay anaphase onset if one or
more chromosomes are misaligned. Genetic manipula-
tions in yeast (Spencer and Hieter, 1992; Wang and Burke,
1995) and laser ablation experiments in mammalian cells
(Rieder et al., 1995) demonstrate that the kinetochores of
misaligned chromosomes generate an M phase checkpoint
Figure 7. Microinjection of mitotic
PtK1 cells with anti-p55CDC antibod-
ies impairs normal progression of late
mitotic events. (A) Slow separation of
sister chromatids and impeded exit
from mitosis by anti-p55CDC microin-
jection. The cell was microinjected
with anti-p55CDC antibodies (1.5 mg/
ml in the micropipette) at early
prometaphase (6 min after NEB). (a)
The first image was taken 13 min later
when the cell was at late
prometaphase. (b) The chromosomes
reached the metaphase plate. (c)
Anaphase initiated after a short delay
of z26 min. (c–g) Separation of sister
chromatids was very slow, requiring
over 50 min before the sister chroma-
tids reached the spindle poles. The cell
failed to undergo cytokinesis, and ex-
ited mitosis as a binucleate cell (arrow-
heads in h). To the right of the microin-
jected cell, an untreated cell progressed
through a normal mitosis. The asterisk
in h denotes one of the progeny of this
normal division. (B) Inhibition of sister
chromatid separation by anti-p55CDC
microinjection. The cell was injected at
late prometaphase with anti-p55CDC
antibodies (1.5 mg/ml). (a) The first ev-
idence of chromatid segregation was
seen 5 min after the start of metaphase
(time point 5 0 min). (b–h) Despite pulling forces evident from stretching of the kinetochore regions (e, arrows), full separation of sister
chromatid arms was never achieved. Bars, 5 mm.
Table II. Duration of Prometaphase in PtK1 Cells in Minutes
Injection (pipette concentration) No. of cells analyzed NEB-metaphase Lb-metaphase* Lb-anaphase‡
No. of cells arrested
at metaphase
mean 6 SD mean 6 SD mean 6 SD
None 10 18.0 6 5.3 7.3 6 4.5 14.8 6 4.4 0
Rabbit IgG (8.0 mg/ml) 10 16.8 6 3.8 8.9 6 2.8 17.4 6 6.3 0
Anti-p55CDC (1.0 mg/ml) 10 19.0 6 4.1 8.4 6 3.2 35.0 6 8.7§ 3
A fresh isolate of PtK1 cells was used. Data are from three independent experiments. *Last chromosome to biorientate (Lb) to formation of metaphase plate. ‡Last chromosome to
biorientate (Lb) to onset of anaphase. §Significantly different from other values; P , 0.01.The Journal of Cell Biology, Volume 141, 1998 1402
signal that inhibits anaphase onset until chromosomes are
properly attached to the spindle microtubules.
Labeling with anti-p55CDC antibodies and expression
of GFP-p55CDC fusion proteins showed that p55CDC is
present diffusely and also concentrated at kinetochores
and other spindle structures in cultured mitotic cells. In in-
terphase, p55CDC appears to be present at reduced levels
diffusely in the nucleus and cytoplasm with a concentra-
tion in two dots, perhaps centrioles, within the centrosome.
During M phase, immunofluorescence and p55CDC-
GFP localization show that the concentration of p55CDC
at the kinetochores changes with progressive stages of mi-
tosis. Up to and including prophase, the majority of the
protein is diffuse with some concentration in the nucleus.
At late mitotic prophase, the protein begins to be found
associated with kinetochores. It remains there until late telo-
phase, when the p55CDC protein wanes in abundance.
During chromosome congregation in prometaphase, the
anti-p55CDC immunolabeling and the p55CDC-GFP flu-
orescence are most intense on kinetochores of chromo-
somes near the poles, and diminishes as chromosomes
move closer to metaphase plate. These changes suggest
that p55CDC concentration progressively diminishes at ki-
netochores as chromosomes establish stable attachments
to the spindle. These dynamics in kinetochore association
are similar to changes with other kinetochore elements, in-
cluding the 3F3/2 phosphoepitope, the Mad2 protein, and
the Bub1 protein, all implicated as components of the
spindle checkpoint (Campbell and Gorbsky, 1995; Chen et
al., 1996; Li and Benezra, 1996; Taylor and McKeon, 1997).
Figure 8. Tracking of anti-p55CDC antibody injected into living
cells. Cells were microinjected with anti-p55CDC, observed for a
time, and then fixed for immunofluorescence to determine the lo-
calization of the injected antibody. Cells were colabeled with hu-
man autoimmune antibodies to localize kinetochores. (a) PtK1
cell arrested at metaphase after microinjection with anti-p55CDC
at early prometaphase. (b) An anti-p55CDC–microinjected PtK1
cell at late anaphase. The cell was microinjected at late
prometaphase. (c) A anti-p55CDC–microinjected PtK1 cell at late
telophase. The antibodies were introduced at late prometaphase.
Note that the microinjected anti-p55CDC antibody remained
bound to kinetochores even at late telophase. Bar, 10 mm.
Figure 9. Expression of 3F3/2 phosphoepitope at the kineto-
chores of anti-p55CDC microinjected PtK1 cells. (A) Similar to
p55CDC signal, the intensity of the fluorescent label of 3F3/2
epitope varies among chromosomes with different positions
along the spindle. The kinetochores of chromosomes closer to
spindle poles possess brighter 3F3/2 and p55CDC signals (arrows
in early prometaphase and mid prometaphase rows) compared
with kinetochores of aligned chromosomes (arrowheads in early
prometaphase and mid prometaphase rows). At late prometa-
phase and metaphase the 3F3/2 signal disappears from the kine-
tochores of aligned chromosomes, while p55CDC is still present
at all kinetochores. One misaligned chromosome having a bright
p55CDC signal also shows strong labeling with the 3F3/2 anti-
body (arrows in late prometaphase row). The spindle poles that
are labeled by both p55CDC and 3F3/2 are denoted with open ar-
rowheads. (B) The 3F3/2 phosphoepitope expression reappears
at the kinetochores of anti-p55CDC injected cells at metaphase if
the spindle is destroyed with nocodazole. (a) At 12:35 the early
prometaphase cell was injected with antibodies against p55CDC
(1.0 mg/ml). At 12:55, all the chromosomes were aligned at the
spindle equator. Nocodazole (5 mg/ml) was added at 12:57. (b) The
cell was fixed 15 min later, and was immunolabeled to detect in-
jected anti-p55CDC and the 3F3/2 phosphoepitope. Bars, 5 mm.Kallio et al. p55CDC Regulates Cell Division Progression 1403
p55CDC is Associated with Mad2 and the APC
in Mitosis
The spindle checkpoint signal appears to function by in-
hibiting the M phase ubiquitin ligase called the APC. Re-
cent studies show that Mad2 protein does not bind the
APC in interphase, but does in M phase, and inhibits APC
activity (Li et al., 1997). The concentration of Mad2 pro-
tein does not appear to vary with the cell cycle (our un-
published observation) and, in yeast, Mad2 protein does
not appear to be phosphorylated (Hartwick and Murray,
1995). Thus, a likely mechanism for cell cycle regulation of
Mad2 activity is through complex formation with other
cell cycle–regulated proteins. Our immunoprecipitation
and immunoblotting experiments revealed that in extracts
prepared from M phase, but not interphase cells, p55CDC
is complexed with Mad2. Similarly, we found that p55CDC
was also associated with the APC in M phase, but not in-
terphase extracts. Recently, Cdc20 of budding yeast and
Slp1 of fission yeast were shown to complex with Mad2, al-
though the association in these organisms was not re-
ported to be cell cycle–dependent (Hwang et al., 1998;
Kim et al., 1998). Lim et al. (1998) also recently reported
that tagged forms of Cdc20 and Cdc23, a component of the
yeast APC, when overexpressed in S. cerevisiae, can be
coimmunoprecipitated, but again no cell cycle dependence
of this association was demonstrated in this organism.
The presence of both p55CDC and Mad2 complexed
with the APC prompted us to ask whether Mad2 binding
to the APC might depend on p55CDC. We first deter-
mined that p55CDC and Mad2 were complexed in the ab-
sence of APC. Second, quantitative immunoprecipitation
of the p55CDC protein coprecipitated some of the APC
and Mad2 from the cell extracts. However, the superna-
tant remaining after p55CDC immunoprecipitation con-
tained significant amounts of both APC and Mad2. This
residual APC and Mad2 were not complexed. One expla-
nation for this result is that Mad2 association with the
APC is mediated by p55CDC.
Microinjection of Antibody to p55CDC Interferes with 
Normal Mitotic Timing
Several related mitotic events—anaphase onset, anaphase
chromatid movement, and exit from mitosis—are blocked
or delayed by microinjection of anti-p55CDC antibody.
The multiple effects detected after injection of anti-
p55CDC antibody suggest that the protein is important in
several pathways, or in a single pathway that regulates oth-
ers. In cells injected with anti-p55CDC antibodies, we did
not detect alterations in the movement of chromosomes
during prometaphase. Moreover, the chromosome oscilla-
tions and stretching at the spindle equator at metaphase
appeared typical, even in injected cells that showed signifi-
cant delays in the onset of anaphase.
Many mitotic cells arrested transiently at metaphase
after anti-p55CDC antibody injection, suggesting that
p55CDC function is involved in the metaphase-to-ana-
phase transition. In PtK1 cells this transient metaphase ar-
rest was often followed by an aberrant progression of
anaphase. Sister chromatid movements were slow, and
cells sometimes failed to complete cytokinesis or decon-
dense their chromosomes. Thus, p55CDC-dependent events
are also apparently essential in late mitosis. However, cells
microinjected at late metaphase or anaphase completed
division without notable effects. This result suggests that
by late metaphase p55CDC has completed its functions, or
that it becomes immune to antibody perturbation.
The precise mechanisms by which antibody injection af-
fects mitotic progression is uncertain. For the effects of the
antibody in delaying the metaphase-to-anaphase transi-
tion, our favored hypothesis is that the anti-p55CDC anti-
body interferes with the requisite ubiquitination of ana-
phase inhibitor proteins by the APC. In budding yeast, the
Cdc20, a protein related to p55CDC, is required for timely
degradation of the anaphase inhibitor protein Pds1 (Visin-
tin et al., 1997; Lim et al., 1998) and mitotic cyclin Clb2
(Lim et al., 1998). Thus, anti-p55CDC antibody injections
may also delay onset of anaphase by interfering with the
APC-dependent destruction of mammalian cyclin A. In
Drosophila, the presence of nondegradable forms of cyclin
A have been shown to delay onset of anaphase (Sigrist et
al., 1995). Moreover, mutations in the Drosophila fizzy
gene product, another protein related to p55CDC, blocks
destruction of mitotic cyclins including cyclin A, and in-
duces cell cycle arrest at metaphase (Sigrist et al., 1995).
To our knowledge, the very slow anaphase movements
of chromatids seen in the injected PtK1 cells that enter
anaphase are without precedents in antibody microinjec-
tion experiments. Qualitatively similar effects in mamma-
lian cells are seen after treatment with low concentrations
of the microtubule-stabilizing agent taxol (Rieder et al.,
1994; Waters et al., 1996). Thus, p55CDC may be impor-
tant in regulating microtubule dynamics in anaphase. Dis-
ruption of microtubule dynamics at metaphase normally
activates the 3F3/2 phosphoepitope at kinetochores. How-
ever, in anti-p55CDC-injected cells that have progressed
to metaphase, the 3F3/2 phosphoepitope is extinguished,
suggesting that microtubule dynamics before anaphase are
sufficiently normal to turn off the spindle checkpoint.
Thus, it appears that the metaphase delay induced by anti-
p55CDC antibody injection is independent of effects on
microtubule dynamics, and occurs downstream of the spin-
dle checkpoint. Anti-p55CDC antibody could block or de-
lay APC-mediated degradation of proteins whose destruc-
tion is necessary for normal anaphase spindle function.
One such protein identified in budding yeast is Ase1. This
protein is required for spindle elongation and separation
of the spindle poles during anaphase B (Pellman et al.,
1995). The gene product is an APC substrate, and is degra-
dated as the cells undergo cytokinesis (Juang et al., 1997).
If protein destruction is prevented by expressing a nonde-
gradable Ase1, the spindle disassembly is delayed and the
cells exhibit a slow anaphase (Juang et al., 1997).
The third general result from cell injection with anti-
p55CDC antibody is failure to exit mitosis. Once more we
hypothesize that this effect may be attributable to the fail-
ure of the APC to target appropriate substrates for ubiq-
uitination. In this instance, the likely candidate substrates
include isoforms of cyclin B. Cyclin B degradation and the
subsequent inactivation of Cdk1 has been shown to be re-
quired for decondensation of mitotic chromosomes, nu-
clear envelope reassembly, and exit from mitosis (Hollo-
way et al., 1993; Irniger et al., 1995). Microinjecting
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cells results in late anaphase arrest, but anaphase onset
and chromatid movement occur normally (Wheatley et al.,
1997). Similarly, a nondegradable form of cyclin B3 in-
duces cell cycle arrest at late anaphase in Drosophila (Si-
grist et al., 1995). Recently, new members of the Cdc20
protein family were identified in S. cerevisiae. Hct1 and
Cdh1 were both shown to be required for yeast mitotic cy-
clin degradation in an APC-dependent manner (Schwab et
al., 1997; Visentin et al., 1997). Together these results sug-
gest that the failure to degrade different cyclin B isoforms,
and maintenance of high levels of Cdk1 activity may ac-
count for the observed difficulty to exit mitosis.
The mechanisms by which p55CDC itself and its cog-
nate proteins in other species function in regulating cell
cycle events are only beginning to be explored. Moreover,
we cannot at present formally distinguish whether the
anti-p55CDC antibody inhibits or enhances the function
of its target protein in living cells. Our presumption is that
the anti-p55CDC antibody interferes with the ability of
p55CDC to carry out its function, perhaps in mediating in-
teractions between the APC and its substrates. However,
an alternative explanation for the antibody microinjection
results stems from biochemical data indicating that a large
proportion of the p55CDC protein is normally degraded
about the time of M phase exit (Weinstein, 1997). Conven-
tional immunofluorescence and p55CDC-GFP studies
suggests that p55CDC disappears from kinetochores after
late anaphase. In our studies, microinjected anti-p55CDC
antibody remains bound to the kinetochore regions of
chromosomes even into early G1 phase for cells that suc-
ceed in exiting M phase. Thus, instead of inhibiting
p55CDC function in living cells, the presence of the anti-
body may preserve p55CDC beyond the time at which it
should normally be degraded, thus interfering with the
normal progression of mitosis.
Our results suggest that mammalian p55CDC is used at
metaphase and anaphase to target several substrates. This
result is in agreement with the latest genetic studies from
yeast, demonstrating that a single targeting protein such as
Cdc20 may be involved in the ubiquitination of several
specific substrates by the APC at appropriate stages of cell
division. Other Cdc20-like proteins such as Hct1/Cdh1 and
Fizzy-related appear to be required at G1 when no Cdc20
is present. However, at present we cannot formally elimi-
nate the possibility that anti-p55CDC antibody injection
into PtK1 cells also affects related members of the mam-
malian family of Cdc20 proteins.
Figure 10. Model for p55CDC function. p55CDC and Mad2 pro-
teins associate with unattached kinetochores in prometaphase
cells (Figs. 2 and 3; Chen et al., 1996) where p55CDC and Mad2
complexes are formed (Fig. 5 A). p55CDC/Mad2 complex forma-
tion does not require the presence of APC (Fig. 5 C). The com-
plex may also contain other yet uncharacterized elements (ques-
tion marks). p55CDC/Mad2 complex production ceases when all
chromosomes are properly oriented in the spindle. The p55CDC/
Mad2 complex then binds the APC (Fig. 5 B). The APC activity
is inhibited by Mad2 (Li et al., 1997). p55CDC participates in tar-
geting the APC to proteolytic substrates (S). Substrate binding
may occur before or after activation of the APC (binding to inac-
tive APC/p55CDC/Mad2 complex shown). The APC is activated
upon loss of Mad2. This activation leads to ubiquitination of mi-
totic target proteins and p55CDC by the APC. At anaphase on-
set, the polyubiquitinated substrate proteins and p55CDC are
proteolysed by the proteosome. During late mitotic events, APC
may associate with other p55CDC-like protein/substrate com-
plexes and be reused for their destruction.Kallio et al. p55CDC Regulates Cell Division Progression 1405
Models of p55CDC Function and the
Spindle Checkpoint
Based on the results presented here and on genetic studies
of p55CDC homologs in other systems, we hypothesize
that p55CDC serves as an essential mitotic targeting com-
ponent for the APC (Fig. 10). We propose that a complex
composed of p55CDC, Mad2, and likely other yet uniden-
tified proteins, is formed during prometaphase in normal
mitosis, and in cells arrested with antimicrotubule drugs.
This complex binds the APC. We postulate that this
p55CDC/Mad2 complex contains elements that prime or
preactivate the APC and others that simultaneously in-
hibit its ubiquitin ligase activity. We speculate that unat-
tached or unstably attached kinetochores serve as staging
areas for catalytic assembly of these p55CDC/Mad2 com-
plexes, which are released to bind the APC throughout the
cell. We suggest that the inhibitory capability of these
complexes spontaneously decays, but in the presence of
unattached kinetochores they continue to be produced.
Thus, in a normal cell the checkpoint is maintained until
the last chromosome achieves bipolar attachment to the
spindle. The presence of a microtubule poison will artifi-
cially produce unattached kinetochores, and thus will per-
petuate inhibitor complex production.
Upon attachment of the final chromosome, inhibitor
production ceases. We suggest that, at a certain threshold
of decay of the inhibitory complex, an autocatalytic mech-
anism is initiated to assure cell-wide spontaneous activa-
tion of the APC. At the molecular level we speculate that
activation involves loss of the inhibitory components (e.g.,
Mad2) with retention of the essential targeting compo-
nents (e.g., p55CDC until it too is degraded by APC-medi-
ated ubiquitination). While highly speculative, this model
does propose testable predictions. For example, it predicts
that p55CDC and Mad2 should be transient components
of kinetochores in prometaphase cells. Second, it predicts
that inhibitory components such as Mad2, but not target-
ing components such as p55CDC, should be released from
the APC after activation of the ubiquitin ligase activity.
In summary, we have presented evidence that p55CDC
participates in the mammalian checkpoint pathway that
regulates various processes of M phase, and is involved in
the APC-mediated protein proteolysis.
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